Showing results (51-60 of 66) with videos related to
Sort By:
Pageof 7
Substance Abuse|September 14, 2021
Emotional reactions of trained overdose responders who use opioids following intervention in an overdose eventLaura Brandt, Aimee N C Campbell, Jermaine D Jones, et al.Journal of Psychoactive Drugs|September 12, 2018
The PPARγ Agonist Pioglitazone Fails to Alter the Abuse Potential of Heroin, But Does Reduce Heroin Craving and AnxietyJermaine D Jones, Adam Bisaga, Verena E Metz, et al.Pharmacology, Biochemistry, and Behavior|October 12, 2017
Pioglitazone, a PPARγ agonist, reduces nicotine craving in humans, with marginal effects on abuse potentialJermaine D Jones, Sandra D Comer, Verena E Metz, et al.Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|April 11, 2017
Effects of Ibudilast on the Subjective, Reinforcing, and Analgesic Effects of Oxycodone in Recently Detoxified Adults with Opioid DependenceVerena E Metz, Jermaine D Jones, Jeanne Manubay, et al.Drugs (Abingdon, England)|July 11, 2022
UNDERSTANDING PREFERENCES FOR TYPE OF TAKE-HOME NALOXONE DEVICE: INTERNATIONAL QUALITATIVE ANALYSIS OF THE VIEWS OF PEOPLE WHO USE OPIOIDSJoanne Neale, Adrian Farrugia, Aimee N Campbell, et al.Psychopharmacology|June 9, 2021
Relative potency of intravenous oxymorphone compared to other µ opioid agonists in humans - pilot study outcomesShanna Babalonis, Sandra D Comer, Jermaine D Jones, et al.Journal of Substance Abuse Treatment|August 20, 2020
Factors associated with withdrawal symptoms and anger among people resuscitated from an opioid overdose by take-home naloxone: Exploratory mixed methods analysisJoanne Neale, Nicola J Kalk, Stephen Parkin, et al.Pain|May 28, 2013
Buprenorphine/naloxone as a promising therapeutic option for opioid abusing patients with chronic pain: reduction of pain, opioid withdrawal symptoms, and abuse liability of oral oxycodonePerrine Roux, Maria A Sullivan, Julien Cohen, et al.Behavioural Pharmacology|April 19, 2022
The effects of acute oral naltrexone pretreatment on the abuse potential of intranasal methamphetamine, and the relationship between reward/punishment sensitivity and methamphetamine's effectsJermaine D Jones, Mudassir Mumtaz, Nehal P Vadhan, et al.Drug and Alcohol Dependence|June 16, 2022
A randomized clinical trial of the effects of brief versus extended opioid overdose education on naloxone utilization outcomes by individuals with opioid use disorderJermaine D Jones, Aimee N Campbell, Laura Brandt, et al.Pageof 7